• About us
• Contact

Advertisement

Organisation › Details

A. Menarini Industrie Farmaceutiche Riunite S.r.l. (Menarini IFR)

The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4.4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, oncology, pneumology, gastroenterology, infectious diseases, diabetology, inflammation, and analgesia. With 18 production sites and 9 Research and Development centers, Menarini's products are available in 140 countries worldwide. *

 

	Start	1992-07-01 existent
	Group	Menarini (Group)
	Industry	pharmaceutical
	Industry 2	diagnostics (medical/biological)
	Region	Firenze (FI) (Florence)
	Country	Italy
	Street	1/3 Sede Via Sette Santi
	City	50131 Florence
	Tel	+39-055-56801
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2024-01-04)
	Currency	USD
	Annual sales	4,400,000,000 (turnover, annual (2023?) 2023-12-31)
		* Document for »About Section«: Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY.
		Record changed: 2024-01-20

Advertisement

More documents for Menarini (Group)

• [1] Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY....
• [2] NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence....
• [3] Stemline Therapeutics, Inc.. (5/4/20). "Press Release: Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million". Florence & New York, NY....
• [4] Menarini Silicon Biosystems S.p.A.. (9/19/19). "Press Release: Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee". Bologna....
• [5] Curetis N.V.. (4/11/19). "Press Release: Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019". Amsterdam & Holzgerlingen....
• [6] Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow....
• [7] Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen....
• [8] Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence....
• [9] Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path"....
• [10] Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.